Remember meForgot password?
    Log in with Twitter
Press Release

Zofran Lawsuits Consolidated In Boston MDL Number 2657 Hit 160 Cases reports on cases consolidated in multidistrict litigation in Boston, Massachusetts, which now number around 160. These cases are being overseen by the Honorable Judge F. Dennis Saylor IV. All include common allegations that anti-nausea medication Zofran, manufactured by GlaxoSmithKline, can cause serious birth defects to develop in babies growing in utero when exposed to them through their mothers.

The consolidation of these cases is formed to help ensure that litigation can run more smoothly and efficiently. It helps to avoid duplicate discovery and different rulings from multiple judges, while conserving the money and time of everyone involved.

At this time, new lawsuits connecting the drug to birth defects are still able to be filed, and many expect the number of cases involved in the MDL to continue to grow.

Despite being the subject of much controversy surrounding expectant mothers, Zofran was never approved to treat pregnant women or tested for safety on this consumer group. It was approved by the U.S. Food and Drug Administration specifically to treat individuals suffering from nausea and vomiting after undergoing chemotherapy, radiation, or anesthesia. After this approval, however, manufacturer GSK began to market the drug as a morning sickness treatment “off-label” to OB/Gyns and the general public.

After women used the drug during the first trimester of their pregnancy to combat nausea, many alleged that they gave birth to children with defects. These women now suggest that exposure to Zofran while in the womb caused their developing babies these defects. Multiple studies from across the world also seem to support this connection.

Birth defects allegedly caused by Zofran are cleft lip and palate, clubfoot, kidney defects, atrial septal defect and ventricular septal defect, transposition of the greater vessels, tetralogy of fallot and respiratory disorders.

By December 3rd of this year, the U.S. District Court for Massachusetts had issued 5 orders regarding trial preparations for the Zofran birth defect lawsuits. As things progress, Attorney Michael Monheit is working with other attorneys at Monheit Law to ensure that everyone affected will be able to explore their legal rights. Families, mothers, and children may be entitled to compensation. Monheit Law is offering free legal consultations for those who were prescribed Zofran while pregnant and who subsequently gave birth to a child with defects.

To ask questions or request additional information on Zofran birth defect lawsuits, contact Michael Monheit, Esq. by calling (877) 620-8411.



Michael Monheit
1368 Barrowdale Road, Rydal, PA 19046